investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Pharmacogenetics of Phase II Drug Metabolizing Enzymes

Richard M Weinshilboum

2 Collaborator(s)

Funding source

National Institute of General Medical Sciences (NIH)

Liewei Wang

Mayo Clinic (Rochester)

Rochester, United States

Related projects

Elizabeth Mittendorf

Immunologic Aspects of Triple Negative Breast Cancer and the Effects of Neoadjuvant Systemic Therapy

Breast

Jun-Lin Guan

Molecular Analysis of Signal Transduction in Cancer Development and Progression

Breast

Mauricio J Reginato

Role of Nutrient Sensor O-GlcNAc Transferase in Regulating Cancer

Breast

Zena Werb

Role of Metalloproteinases in Mammary Gland Remodeling

Breast

Chandra Bartholomeusz

Development of Targeted Therapy for ERK Pathway in Breast Cancer

Breast

Ralph Scully

Analysis of BRCA1 Recombination Functions

Breast

Fraser Symmans

Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer

Breast

Hugh S. Gannon

Extraordinary responder cell lines reveal unique targetable genetic dependencies

Breast

Steven I Reed

The Role of Cyclin E in Growth Control and Tumorogenesis

Breast